OMCL
Omnicell, Inc.

693
Loading...
Loading...
News
all
press releases
OMCL or HIMS: Which Is the Better Value Stock Right Now?
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Zacks·18h ago
News Placeholder
More News
News Placeholder
The Zacks Analyst Blog Highlights Butterfly Network, Omnicell, NVIDIA, Palantir and IBM
Butterfly Network and Omnicell stand out as top health-tech stocks benefiting from AI, machine learning, and quantum advancements in healthcare, alongside NVIDIA, Palantir, and IBM driving transformative innovations.
Zacks·4d ago
News Placeholder
NVIDIA, AI & Quantum Leaders Drive Health Tech: 2 Stocks to Buy
Butterfly Network and Omnicell emerge as standout health tech stocks as AI and quantum breakthroughs reshape diagnostics and medication management.
Zacks·5d ago
News Placeholder
Wall Street Analysts Think Omnicell (OMCL) Could Surge 39.36%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 39.4% in Omnicell (OMCL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks·5d ago
News Placeholder
Why Is Inspire (INSP) Up 7.5% Since Last Earnings Report?
Inspire (INSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·13d ago
News Placeholder
Earnings Estimates Rising for Omnicell (OMCL): Will It Gain?
Omnicell (OMCL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Zacks·21d ago
News Placeholder
Wall Street Analysts Believe Omnicell (OMCL) Could Rally 34.18%: Here's is How to Trade
The consensus price target hints at a 34.2% upside potential for Omnicell (OMCL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks·21d ago
News Placeholder
Wall Street Analysts See a 44.47% Upside in Omnicell (OMCL): Can the Stock Really Move This High?
The mean of analysts' price targets for Omnicell (OMCL) points to a 44.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·2mo ago
News Placeholder
Omnicell (OMCL) Beats Q2 Earnings and Revenue Estimates
Omnicell (OMCL) delivered earnings and revenue surprises of +45.16% and +4.99%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Can Sustained Product Demand Drive HIMS Stock Before Q2 Earnings?
Hims & Hers benefits from strong product demand and subscriber growth ahead of second-quarter 2025 earnings, fueled by weight loss and specialty care uptake.
Zacks·2mo ago

Latest OMCL News

View

Advertisement. Remove ads.

Advertisement. Remove ads.